AQR Capital Management »

Protalix Biotherapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $66k 31k 2.17
2024-06-30 $67k 57k 1.18

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Broadcom (AVGO)
Bristol Myers Squibb (BMY)
Alphabet Cap Stk Cl A (GOOGL)
Edison International (EIX)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl C (GOOG)
Comfort Systems USA (FIX)
Micron Technology (MU)
Booking Holdings (BKNG)
Ge Vernova (GEV)
Chubb (CB)

View all positions for AQR Capital Management

Top funds holding Protalix Biotherapeutics

BlackRock
MAK Capital One
Renaissance Technologies
Northern Trust
Geode Capital Management
State Street Corporation
Stratos Wealth Partners
Vanguard Group
Vanguard Portfolio Management
Prospera Financial Services
Opaleye Management
Morgan Stanley
Dimensional Fund Advisors
UBS Group
Goldman Sachs Group

View all funds holding Protalix Biotherapeutics